| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |